Fas-ligand gene silencing in basal cell carcinoma tissue with small interfering RNA (original) (raw)
Buechner SA et al. Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide. J Clin Invest 1997; 100: 2691–2696. ArticleCASPubMedPubMed Central Google Scholar
Lee SH et al. Fas ligand is expressed in normal skin and in some cutaneous malignancies. Br J Dermatol 1998; 139: 186–191. ArticleCASPubMed Google Scholar
GutierrezSteil C et al. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J Clin Invest 1998; 101: 33–39. ArticleCAS Google Scholar
Jang TJ . Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma. Yonsei Med J 2002; 43: 304–308. ArticleCASPubMed Google Scholar
Hahne M et al. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 1996; 274: 1363–1366. ArticleCASPubMed Google Scholar
Nyhus JK, Wolford C, Feng L, BarberaGuillem E . Direct in vivo transfection of antisense Fas-ligand reduces tumor growth and invasion. Gene Therapy 2001; 8: 209–214. ArticleCASPubMed Google Scholar
Ji JM, Wernli M, Buechner S, Erb P . Fas ligand downregulation with antisense oligonucleotides in cells and in cultured tissues of normal skin epidermis and basal cell carcinoma. J Invest Dermatol 2003; 120: 1094–1099. ArticleCASPubMed Google Scholar
Elbashir SM et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494–498. ArticleCASPubMed Google Scholar
Coburn GA, Cullen BR . Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 2002; 76: 9225–9231. ArticleCASPubMedPubMed Central Google Scholar
Jacque JM, Triques K, Stevenson M . Modulation of HIV-1 replication by RNA interference. Nature 2002; 418: 435–438. ArticleCASPubMed Google Scholar
Gitlin L, Karelsky S, Andino R . Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 2002; 418: 430–434. ArticleCASPubMed Google Scholar
Park WS, Hayafune M, MiyanoKurosaki N, Takaku H . Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells. Gene Therapy 2003; 10: 2046–2050. ArticleCASPubMed Google Scholar
Randall G, Grakoui A, Rice CM . Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc Nat Acad Sci USA 2003; 100: 235–240. ArticleCASPubMed Google Scholar
Hamasaki K et al. Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett 2003; 543: 51–54. ArticleCASPubMed Google Scholar
Jiang M, Milner J . Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 2002; 21: 6041–6048. ArticleCASPubMed Google Scholar
Song EW et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003; 9: 347–351. ArticleCASPubMed Google Scholar
Rubinson DA et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003; 33: 401–406. ArticleCASPubMed Google Scholar
Martinez MA et al. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS 2002; 16: 2385–2390. ArticleCASPubMed Google Scholar
Brummelkamp TR, Bernards R, Agami R . Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002; 2: 243–247. ArticleCASPubMed Google Scholar
Scherr M et al. Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 2003; 101: 1566–1569. ArticleCASPubMed Google Scholar
Hutvagner G, Simard MJ, Mello CC, Zamore PD . Sequence-specific inhibition of small RNA function. PLoS Biol 2004; 2: 465–475. ArticleCAS Google Scholar
Aoki Y et al. RNA interference may be more potent than antisense RNA in human cancer cell lines. Clin Exp Pharmacol Physiol 2003; 30: 96–102. ArticleCASPubMed Google Scholar
Dykxhoorn DM, Novina CD, Sharp PA . Killing the messenger: short rnas that silence gene expression. Nat Rev Mol Cell Biol 2003; 4: 457–467. ArticleCASPubMed Google Scholar
Hasuwa H, Kaseda K, Einarsdottir T, Okabe M . Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett 2002; 532: 227–230. ArticleCASPubMed Google Scholar
McCaffrey AP et al. Gene expression – RNA interference in adult mice. Nature 2002; 418: 38–39. ArticleCASPubMed Google Scholar
Sorensen DR, Leirdal M, Sioud M . Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 2003; 327: 761–766. ArticleCASPubMed Google Scholar
McCaffrey AP et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 2003; 21: 639–644. ArticleCASPubMed Google Scholar
Hull D, Timmons L . Methods for delivery of double-stranded RNA into Caenorhabditis elegans. Methods Mol Biol 2004; 265: 23–58. CASPubMed Google Scholar
Filleur S et al. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. Cancer Res 2003; 63: 3919–3922. CASPubMed Google Scholar
Calegari F et al. Tissue-specific RNA interference in postimplantation mouse embryos with endoribonuclease-prepared short interfering RNA. Proc Natl Acad Sci USA 2002; 99: 14236–14240. Epub 2002 Oct 21. ArticleCASPubMedPubMed Central Google Scholar
Bachmann F et al. Ultraviolet light downregulates CD95 ligand and trail receptor expression facilitating actinic keratosis and squamous cell carcinoma formation. J Invest Dermatol 2001; 117: 59–66. ArticleCASPubMed Google Scholar